DE69617415T2 - Kanzeröse metastasenbildung unterdrückendes antikrebsmittel - Google Patents

Kanzeröse metastasenbildung unterdrückendes antikrebsmittel

Info

Publication number
DE69617415T2
DE69617415T2 DE69617415T DE69617415T DE69617415T2 DE 69617415 T2 DE69617415 T2 DE 69617415T2 DE 69617415 T DE69617415 T DE 69617415T DE 69617415 T DE69617415 T DE 69617415T DE 69617415 T2 DE69617415 T2 DE 69617415T2
Authority
DE
Germany
Prior art keywords
anticrecellent
canceled
metastasis formation
suppressive
formation suppressive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69617415T
Other languages
English (en)
Other versions
DE69617415D1 (de
Inventor
Takaaki Hasegawa
Kenichi Miyamoto
Mitsuo Kawase
Yasuko Yoshida
Tadahiko Inukai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NGK Insulators Ltd
Biseiken Co Ltd
Original Assignee
NGK Insulators Ltd
Biseiken Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NGK Insulators Ltd, Biseiken Co Ltd filed Critical NGK Insulators Ltd
Application granted granted Critical
Publication of DE69617415D1 publication Critical patent/DE69617415D1/de
Publication of DE69617415T2 publication Critical patent/DE69617415T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02Acyclic radicals
    • C07H7/027Keto-aldonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69617415T 1996-02-08 1996-02-08 Kanzeröse metastasenbildung unterdrückendes antikrebsmittel Expired - Fee Related DE69617415T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1996/000268 WO1997028807A1 (fr) 1996-02-08 1996-02-08 Substance anticancereuse inhibant le processus metastatique cancereux

Publications (2)

Publication Number Publication Date
DE69617415D1 DE69617415D1 (de) 2002-01-10
DE69617415T2 true DE69617415T2 (de) 2002-08-01

Family

ID=14152897

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69617415T Expired - Fee Related DE69617415T2 (de) 1996-02-08 1996-02-08 Kanzeröse metastasenbildung unterdrückendes antikrebsmittel

Country Status (7)

Country Link
US (1) US6083931A (de)
EP (1) EP0821963B1 (de)
KR (1) KR19980703698A (de)
CA (1) CA2217710C (de)
DE (1) DE69617415T2 (de)
ES (1) ES2169223T3 (de)
WO (1) WO1997028807A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7018406B2 (en) 1999-11-17 2006-03-28 Corevalve Sa Prosthetic valve for transluminal delivery
FR2800984B1 (fr) 1999-11-17 2001-12-14 Jacques Seguin Dispositif de remplacement d'une valve cardiaque par voie percutanee
US20070043435A1 (en) 1999-11-17 2007-02-22 Jacques Seguin Non-cylindrical prosthetic valve system for transluminal delivery
JP5593545B2 (ja) 2006-12-06 2014-09-24 メドトロニック シーブイ ルクセンブルク エス.アー.エール.エル. 弁輪に固定された自己拡張型弁の経心尖的送達のためのシステムおよび方法
US8926693B2 (en) 2010-02-17 2015-01-06 Medtronic, Inc. Heart valve delivery catheter with safety button
US8475523B2 (en) 2010-02-17 2013-07-02 Medtronic, Inc. Distal tip assembly for a heart valve delivery catheter
US8518106B2 (en) 2010-02-17 2013-08-27 Medtronic, Inc. Catheter assembly with valve crimping accessories
US9414914B2 (en) 2010-02-24 2016-08-16 Medtronic Ventor Technologies Ltd. Catheter assembly with valve crimping accessories
EP3858293A1 (de) 2010-04-21 2021-08-04 Medtronic, Inc. Prothesenklappe mit dichtungselementen
US9387077B2 (en) 2010-05-27 2016-07-12 Medtronic Vascular Galway Catheter assembly with prosthesis crimping and prosthesis retaining accessories
FR3034642B1 (fr) 2015-04-07 2021-01-15 Benjamin Faurie Introducteur pour ensemble de remplacement d'une valve cardiaque ou pour ensemble d'angioplastie coronaire
EP3522800B1 (de) 2016-10-07 2021-07-14 Electroducer Anordnung zum ersetzen einer herzklappe oder einer koronarangioplastieanordnung
WO2019185880A1 (fr) 2018-03-29 2019-10-03 Electroducer Ensemble de pose d'un implant cardiaque, aortique ou arteriel avec assistance de stimulation par catheter pour voie arterielle ou veineuse peripherique
FR3079404B1 (fr) 2018-03-29 2020-03-06 Electroducer Ensemble de remplacement d’une valve cardiaque avec assistance de stimulation par voie arterielle ou veineuse peripherique
JP2021042189A (ja) * 2019-09-06 2021-03-18 均 石井 抗がん剤。

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60190791A (ja) * 1984-03-09 1985-09-28 Kanto Ishi Pharma Co Ltd シアル酸誘導体およびその製造法
JPS6183125A (ja) * 1984-09-28 1986-04-26 Kanto Ishi Pharma Co Ltd 癌転移阻害剤
JPS62132895A (ja) * 1985-12-05 1987-06-16 Mect Corp 癌転移阻害剤の製造方法
JPH0684307B2 (ja) * 1986-03-26 1994-10-26 メクト株式会社 新規癌転移阻害剤
JPH03245784A (ja) * 1990-02-23 1991-11-01 Toshiba Corp モータ制御装置
US5438125A (en) * 1991-03-06 1995-08-01 Nippon Zoki Pharmaceutical Co., Ltd. Sialic acid derivatives
WO1992018610A2 (en) * 1991-04-19 1992-10-29 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for endothelial binding
EP0521692A3 (en) * 1991-07-02 1993-02-03 The Biomembrane Institute Inhibition of tumor cell metastasis potential and invasiveness by chemically-defined oligosaccharides, their derivatives, mimetics and antibodies directed to them
JPH06245784A (ja) * 1993-02-19 1994-09-06 Taiyo Kagaku Co Ltd シアル酸及びシアル酸誘導体含有組成物の製造方法
GB9422584D0 (en) * 1994-02-15 1995-01-04 Medical Res Council Immunomodulation using oligosaccharides

Also Published As

Publication number Publication date
CA2217710C (en) 2002-05-28
WO1997028807A1 (fr) 1997-08-14
CA2217710A1 (en) 1997-08-14
DE69617415D1 (de) 2002-01-10
EP0821963B1 (de) 2001-11-28
ES2169223T3 (es) 2002-07-01
EP0821963A4 (de) 1999-07-14
EP0821963A1 (de) 1998-02-04
KR19980703698A (ko) 1998-12-05
US6083931A (en) 2000-07-04

Similar Documents

Publication Publication Date Title
DK0966430T3 (da) Anti-flammatoriske forbindelser
DE69729672D1 (de) Biosensor
NO20002521L (no) Separatorer
DE69617415D1 (de) Kanzeröse metastasenbildung unterdrückendes antikrebsmittel
DK199801111A (da) Papirfremstillingsproces
DE69833039D1 (de) Trennprozess
DE69507562T2 (de) Kopiergerät
DE69841297D1 (de) Toner
DE69727334D1 (de) Kopiergerät
DE59809844D1 (de) Stoffauflauf
DE69719749T2 (de) Aufhängevorrichtung
ATA105297A (de) Laufhilfe
BR9711681A (pt) Novos m-todos
KR960028936U (ko) 탈수기
DE69815048D1 (de) Kopiergerät
DE69708063T2 (de) Radaufhängung
ID19965A (id) Metoda pembutiran basah
KR950022884U (ko) 탈수기
KR970060888U (ko) 탈수장치
SE9503098D0 (sv) Avvattningsanordning
SE9403118D0 (sv) Avvattningsanordning
BR7702011U (pt) Envelo - mídia de poesia
KR970054832U (ko) 탈수기
KR970018029U (ko) 탈수기
KR970018094U (ko) 탈수기

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee